31009-04-8

Basic information

• Product Name: 7-bromoquinoline-4-carboxylic acid
• Synonyms: 7-bromoquinoline-4-carboxylic acid
• CAS NO: 31009-04-8
• Molecular Formula: C10H6BrNO2
• Molecular Weight: 252.06414
• Mol File: 31009-04-8.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 7-bromoquinoline-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 7-bromoquinoline-4-carboxylic acid(31009-04-8)
• EPA Substance Registry System: 7-bromoquinoline-4-carboxylic acid(31009-04-8)

Safety Data

• Hazardous Substances Data: 31009-04-8(Hazardous Substances Data)

Usage

General Description

7-Bromoquinoline-4-carboxylic acid is a chemical compound typically used in the synthesis of specific pharmaceutical drugs and research chemicals. It belongs to the class of compounds known as bromobenzenes, which are aromatic compounds containing a benzene substituted by one or more bromine atoms. Its molecular formula is C10H6BrNO2. This chemical typically appears as a white to off-white powder and should be stored in a cool, dry place to maintain its stability. As with many chemicals of this nature, 7-Bromoquinoline-4-carboxylic acid may pose health risks if handled inappropriately and should be handled using appropriate safety measures.

Upstream product

• 1219834-21-5 7-bromoquinoline-2,4-dicarboxylic acid 
• 6326-79-0 6-bromoisatin 
• 113-24-6 sodium pyruvate 
• 52415-29-9 6-bromo-1H-indole 

Downstream Products

• 220844-76-8 methyl 7-bromo-4-quinolinecarboxylate 
• 1474034-00-8 7-(phenylamino)quinoline-4-carboxylic acid 

Relevant articles and documents

Quinoline formamide compound as well as preparation method and application thereof

The invention discloses quinoline formamide compounds as well as a preparation method and application thereof. Specifically, the invention relates to a compound represented by a formula (I) as shown in the specification or a tautomer, a meso-racemate, a r

NOVEL FAP INHIBITORS

The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.

NOVEL FAP INHIBITORS

The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.